Fulminant demyelinating encephalomyelitis
Open Access
- 1 December 2015
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
- Vol. 2 (6), e175
- https://doi.org/10.1212/nxi.0000000000000175
Abstract
Objectives: Antibodies to myelin oligodendrocyte glycoprotein (MOG) are detectable in inflammatory demyelinating CNS diseases, and MOG antibody–associated diseases seem to have a better prognosis despite occasionally severe presentations. Methods: We report the case of a 71-year-old patient with acute visual and gait disturbance that dramatically worsened to bilateral amaurosis, tetraplegia, and respiratory insufficiency within a few days. Results: MRI showed multiple progressive cerebral and spinal lesions with diffusion restriction (including both optic nerves) and marginal contrast enhancement. Routine blood and CSF measures including oligoclonal bands were normal. At disease onset, MOG immunoglobulin G was detected (serum titer 1:1,280, corresponding CSF titer was 1:20) and remained positive in patient serum. Aquaporin-4 antibodies were absent at disease onset but seroconverted to positive at week 9. In addition, CSF glial fibrillary acid protein and myelin basic protein levels were very high at onset but decreased during disease course. After 4 months, the patient died despite immunomodulatory treatment. Postmortem neuropathologic examination revealed an acute multiple sclerosis (MS) defined by multiple demyelinating lesions with a pronounced destructive component and loss of astrocytes. Lesion pattern of optic chiasm met MS pattern II characterized by antibody and complement-mediated demyelination. Conclusion: The case with the clinical presentation of an acute demyelinating encephalomyelitis with predominant optic and spinal involvement, absent oligoclonal bands, a histopathology of acute MS pattern II and development of aquaporin-4 antibodies extends the spectrum of MOG antibody–associated encephalomyelitis. Although, MOG antibodies are suspected to indicate a favorable prognosis, fulminant disease courses are possible and warrant an aggressive immunotherapy.Keywords
This publication has 40 references indexed in Scilit:
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75Zeitschrift für Neurologie, 2015
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative StudyJAMA Neurology, 2014
- Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic NeuritisArchives of Neurology, 2012
- Pathology of Demyelinating DiseasesAnnual Review Of Pathology-Mechanisms Of Disease, 2012
- Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system diseaseAnnals of Neurology, 2009
- Persistence of Immunopathological and Radiological Traits in Multiple SclerosisArchives of Neurology, 2008
- Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNature Medicine, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelinationAnnals of Neurology, 2000